These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22808305)

  • 21. A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne.
    Eichenfield LF; Thiboutot D; Shalita A; Swinyer L; Tanghetti E; Tschen E; Parr L
    J Clin Aesthet Dermatol; 2009 Nov; 2(11):21-6. PubMed ID: 20725576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
    Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study.
    Bertolani MB; Rodighiero E; Gandolfi M; Lotti T; Pedrazzi G; Puviani M; Milani M; Feliciani C; Satolli F
    Dermatol Ther; 2021 Jan; 34(1):e14724. PubMed ID: 33377285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
    Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
    Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
    Amar L; Kircik LH
    J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
    Warner GT; Plosker GL
    Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
    Stein Gold L; Lain E; Del Rosso JQ; Gold M; Draelos ZD; Eichenfield LF; Sadick N; Werschler WP; Gooderham MJ; Lupo M
    J Am Acad Dermatol; 2023 Nov; 89(5):927-935. PubMed ID: 37656094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
    Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
    Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study.
    Wolf JE; Kaplan D; Kraus SJ; Loven KH; Rist T; Swinyer LJ; Baker MD; Liu YS; Czernielewski J
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S211-7. PubMed ID: 12963897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.
    Gold MH; Korotzer A
    J Clin Aesthet Dermatol; 2015 Dec; 8(12):22-6. PubMed ID: 26705445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
    Goreshi R; Samrao A; Ehst BD
    J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.
    Zheng Y; Yin S; Xia Y; Chen J; Ye C; Zeng Q; Lai W
    Cutan Ocul Toxicol; 2019 Mar; 38(1):48-54. PubMed ID: 30173582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
    Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
    Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, Observer-blind, Split-face Compatibility Study with Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% gel and Facial Foundation Makeup.
    Bhatia N; Pillai R
    J Clin Aesthet Dermatol; 2015 Sep; 8(9):25-32. PubMed ID: 26430488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
    J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel.
    Harper JC; Kircik LH; Gold M; Hebert AA; Sugarman JL; Green L; Gold LS; Baldwin H; Guenin E; DelRosso JQ
    J Drugs Dermatol; 2024 Mar; 23(3):125-131. PubMed ID: 38443130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.